SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0000950170-23-051118
Filing Date
2023-10-02
Accepted
2023-10-02 16:00:08
Documents
12
Period of Report
2023-09-27
Items
Item 3.01: Notice of Delisting or Failure to Satisfy a Continued Listing Rule or Standard; Transfer of Listing

Document Format Files

Seq Description Document Type Size
1 8-K glto-20230927.htm   iXBRL 8-K 65284
  Complete submission text file 0000950170-23-051118.txt   187885

Data Files

Seq Description Document Type Size
2 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT glto-20230927_pre.xml EX-101.PRE 11420
3 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT glto-20230927_lab.xml EX-101.LAB 14084
4 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT glto-20230927.xsd EX-101.SCH 2449
6 EXTRACTED XBRL INSTANCE DOCUMENT glto-20230927_htm.xml XML 4875
Mailing Address 75 STATE STREET SUITE 100 BOSTON MA 02109
Business Address 75 STATE STREET SUITE 100 BOSTON MA 02109 45-70-70-52-10
Galecto, Inc. (Filer) CIK: 0001800315 (see all company filings)

IRS No.: 371957007 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39655 | Film No.: 231299504
SIC: 2834 Pharmaceutical Preparations